Extended GLP-1 compounds

Details for Australian Patent Application No. 2006224537 (hide)

Owner Novo Nordisk A/S

Inventors Lau, Jesper; Schaffer, Lauge; Dorwald, Florencio Zaragoza; Hansen, Thomas Kruse

Agent Shelston IP

Pub. Number AU-A-2006224537

PCT Pub. Number WO2006/097538

Priority 05102173.1 18.03.05 EP

Filing date 20 March 2006

Wipo publication date 21 September 2006

International Classifications

A61K 38/26 (2006.01) Medicinal preparations containing peptides - Glucagons

C07K 14/605 (2006.01) Peptides having more than 20 amino acids

Event Publications

9 August 2007 PCT application entered the National Phase

  PCT publication WO2006/097538 Priority application(s): WO2006/097538

21 July 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  Application withdrawn under section 141(1). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006224538-Improved method of expression cloning in a host cell

2006224536-Acylated GLP-1 compounds